Company intelligence / Profile preview

Aeropharm

Rudolstadt, Thuringia, Germany

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Aeropharm develops and manufactures generic respiratory medicines, primarily for asthma and COPD, serving as an international center of excellence for Sandoz’s respiratory and ophthalmological generics. Specific clinical results are not publicly disclosed, as it mainly produces approved generics for global distribution[5][6][1].

Therapeutic areas: Pulmonology
Modalities: Small molecule
Industry: Biotech

Partnerships

Sandoz Group (integrated manufacturing and development partner)

Beyond the preview

Go deeper on Aeropharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aeropharm.

Explore the full profile